Last reviewed · How we verify

Treatment of colorectal cancer that has spread to the liver and the pancreas — Treatment Landscape & Competitive Intelligence

Treatment of colorectal cancer that has spread to the liver and the pancreas (disease) competitive landscape: 1 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

1 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Treatment of colorectal cancer that has spread to the liver and the pancreas, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Folfiri folfiri Pfizer chemotherapy DNA replication and repair

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. Pfizer · 1 drug in Treatment of colorectal cancer that has spread to the liver and the pancreas

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Treatment of colorectal cancer that has spread to the liver and the pancreas:

Cite this brief

Drug Landscape (2026). Treatment of colorectal cancer that has spread to the liver and the pancreas — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/treatment-of-colorectal-cancer-that-has-spread-to-the-liver-and-the-pancreas. Accessed 2026-06-10.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing